The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
|Number of pages||3|
|Journal||Expert Review of Pharmacoeconomics and Outcomes Research|
|Publication status||Published - 2 Nov 2017|
- Central and Eastern Europe
- health technology assessment
- managed entry agreements